PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL VARICELLA VACCINATION IN THE UNITED KINGDOM

被引：0
|
作者：
Jamet, N. [1 ]
George, M. [2 ]
Shah, H. A. [3 ]
Oliyide, A. [3 ]
Zerda, I [4 ]
Cristeau, O. [5 ]
Casabona, G. [1 ]
机构：
[1] GSK, Wavre, Belgium
[2] Hari Thrivikramji, Wavre, Belgium
[3] GSK, London, England
[4] Creativ Ceut, Krakow, Poland
[5] Creativ Ceut, Paris, France
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH161
引用
收藏
页码：S221 / S222
页数：2
相关论文
共 50 条
  • [31] A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China
    Zhuang, Gui-Hua
    Pan, Xin-Juan
    Wang, Xue-Liang
    VACCINE, 2008, 26 (35) : 4608 - 4616
  • [32] Cost-effectiveness and potential impact of rotavirus vaccination in the United States
    Widdowson, Marc-Alain
    Meltzer, Martin I.
    Zhang, Xinzhi
    Bresee, Joseph S.
    Parashar, Umesh D.
    Glass, Roger I.
    PEDIATRICS, 2007, 119 (04) : 684 - 697
  • [33] COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL VACCINATION WITH PENTAVALENT VACCINE IN RUSSIA
    Rudakova, A.
    Ugrekhelidze, D.
    Sharomi, O.
    Cook, J.
    Nachbar, R.
    Lobzin, Y.
    Briko, N.
    Namazova-Baranova, L.
    Podkolzin, A.
    Chen, Y. H.
    VALUE IN HEALTH, 2020, 23 : S545 - S546
  • [34] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF HERPES ZOSTER VACCINATION FOR OLDER ADULTS IN THE NETHERLANDS
    Van der Pol, S.
    Giannelos, N.
    Joost, S.
    Wilschut, J. C.
    Post, M. J.
    Boersma, C.
    VALUE IN HEALTH, 2022, 25 (12) : S133 - S133
  • [35] COST-EFFECTIVENESS MODEL OF COVID-19 VACCINATION: THE UNITED KINGDOM PERSPECTIVE
    Gojovic, M. Z.
    Pitman, R.
    Pritchard, C.
    Lai, K. Z. H.
    Lundkvist, J.
    Kutikova, L.
    Cosgrove, C.
    Sculpher, M.
    Salisbury, D.
    VALUE IN HEALTH, 2023, 26 (12) : S167 - S167
  • [36] Cost-effectiveness of varicella vaccination programs: an update of the literature
    Rozenbaum, Mark H.
    van Hoek, Albert Jan
    Vegter, Stefan
    Postma, Maarten J.
    EXPERT REVIEW OF VACCINES, 2008, 7 (06) : 753 - 782
  • [37] Varicella, vaccine, cost-effectiveness analyses, and vaccination policy
    Davis, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (07): : 845 - 846
  • [38] Cost-effectiveness of varicella zoster vaccination in older adults
    Anthony M. H. Ho
    Paul Coplan
    Anna Lee
    Gavin M Joynt
    Manoj K Karmakar
    Canadian Journal of Anesthesia, 2006, 53 (Suppl 1): : 26394 - 26394
  • [39] The cost-effectiveness of routine childhood varicella vaccination in Germany
    Banz, K
    Wagenpfeil, S
    Neiss, A
    Goertz, A
    Staginnus, U
    Vollmar, J
    Wutzler, P
    VACCINE, 2003, 21 (11-12) : 1256 - 1267
  • [40] Cost-effectiveness of universal pneumococcal vaccination in Uruguay
    Giachetto Larraz, Gustavo
    Telechea Ortiz, Hector
    Speranza Mourine, Noelia
    Giglio, Norberto
    Cane, Alejandro
    Pirez Garcia, Maria C.
    Lucas Paiva, Liriana
    Pallarese Barrios, Carla
    Gesuele Ruggiero, Juan
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 28 (02): : 92 - 99
12345